French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

The current French guidelines for the treatment of psoriasis date from 2019 and do not include the most up-to-date interventions. The Psoriasis Research Group of the French Society of Dermatology has developed new guidelines to provide updated decision-making algorithms for the systemic treatment of adult patients with moderate-to-severe psoriasis. The algorithms were created following a thorough review of existing psoriasis treatment guidelines and recent publications on new systemic therapies not included in previous recommendations. They propose updated treatment strategies that combine established and emerging systemic therapies for patients with plaque psoriasis and psoriatic arthritis. The working group recommends methotrexate, adalimumab or ustekinumab as the primary systemic treatment for patients with psoriasis without symptomatic comorbidities. Additionally, the guidelines include specific recommendations for long-term management in cases of insufficient response or low disease activity, as well as for treating specific types of psoriasis and managing patients with comorbid conditions or those planning a pregnancy.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-12-30
DOI
https://doi.org/10.1111/jdv.70263
Citations
2
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
1.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

Guillaume Larid, T. Randriamiarana, Julie Charles, Laurie Gouillon et al.
2 citations
Journal of the European Academy of Dermatology and Venereology
Psoriasis: Treatment and Pathogenesis
1.59
article

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

Guillaume Larid, T. Randriamiarana, Julie Charles, Laurie Gouillon, Clarisse Marcombes, Marine Roux, Audrey Melin, Marine Chastagner, C. Berthault, É. Sbidian, M. Masson Regnault, H. Aubert, E. Brenaut, Laëtitia Penso, L. Pina Vegas, C. Labonne, O. Potié, Raphaël Ouakrat, J. Gottlieb, Stéphane Mouret, Sandy Sylvain, Da Hee Pitaud, Marie‐Emeline Marniquet, Floriane Etheve, Lea Canoen, Colombe Bougeard
article en
2 citations

Abstract

The current French guidelines for the treatment of psoriasis date from 2019 and do not include the most up-to-date interventions. The Psoriasis Research Group of the French Society of Dermatology has developed new guidelines to provide updated decision-making algorithms for the systemic treatment of adult patients with moderate-to-severe psoriasis. The algorithms were created following a thorough review of existing psoriasis treatment guidelines and recent publications on new systemic therapies not included in previous recommendations. They propose updated treatment strategies that combine established and emerging systemic therapies for patients with plaque psoriasis and psoriatic arthritis. The working group recommends methotrexate, adalimumab or ustekinumab as the primary systemic treatment for patients with psoriasis without symptomatic comorbidities. Additionally, the guidelines include specific recommendations for long-term management in cases of insufficient response or low disease activity, as well as for treating specific types of psoriasis and managing patients with comorbid conditions or those planning a pregnancy.

Journal of the European Academy of Dermatology and Venereology
Université Paris-Est Créteil (FR), Centre Hospitalier Universitaire de Grenoble (FR), Centre Hospitalier Universitaire de Nantes (FR), Centre Hospitalier Universitaire Henri-Mondor (FR), Communauté urbaine de Lyon (FR), Centre Hospitalier de Niort (FR), Centre Hospitalier Universitaire de Poitiers (FR), Centre d'Investigation Clinique de Nantes (FR), Hôpitaux Universitaires Henri-Mondor (FR), Centre Hospitalier Régional Universitaire de Brest (FR), Polyclinique de Franche Comté (FR)
Good health and well-being
Openalex Percentile: Top 13%
Psoriasis: Treatment and Pathogenesis
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.